The secondary condition for thrombosis is endothelial dysfunction due to the increase in TSS, which leads to endothelial cell dysfunction, resulting in upregulated expression of IKCa2.3, IKCa3.1, AKT1, and P300. Here, EP300 is linked to endothelial dysfunction.